scispace - formally typeset
R

Rosemary Greenwood

Researcher at Bristol Royal Infirmary

Publications -  58
Citations -  4515

Rosemary Greenwood is an academic researcher from Bristol Royal Infirmary. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 26, co-authored 50 publications receiving 4062 citations. Previous affiliations of Rosemary Greenwood include National Health Service & Frenchay Hospital.

Papers
More filters
Journal ArticleDOI

Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial

TL;DR: This study has demonstrated that infliximab at a dose of 5 mg/kg is superior to placebo in the treatment of PG and infliximab treatment should be considered in patients with PG.
Journal ArticleDOI

Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease

TL;DR: A significant increase in fecal ester VOC is associated with compositional shifts in the microbiome of obese NAFLD patients, and these novel bacterial metabolomic and metagenomic factors are implicated in the etiology and complications of obesity.
Journal ArticleDOI

Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study.

TL;DR: Over 1% of the UK population is receiving thyroid hormone replacement with l‐thyroxine (T4) but many patients complain of persistent lethargy and related symptoms on T4 even with normal TSH levels, so a large, community‐based study is attempted to address this issue.
Journal ArticleDOI

Childhood cancer, intramuscular vitamin K, and pethidine given during labour.

TL;DR: The only two studies so far to have examined the relation between childhood cancer and intramuscular vitamin K have shown similar results, and the relation is biologically plausible, meaning the prophylactic benefits against haemorrhagic disease are unlikely to exceed the potential adverse effects from intramuuscularitamin K.
Journal ArticleDOI

Leg length, insulin resistance, and coronary heart disease risk: The Caerphilly Study

TL;DR: Leg length is the component of stature related to insulin resistance and coronary heart disease risk and the reported associations suggest that pre-adult influences are important in the aetiology of coronaryHeart disease and insulin resistance.